Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today the appointment of Christian Hartman, PharmD, MBA, FSMSO, as Director of Clinical Quality and Patient Safety for Pharmacy OneSource. In this role, Hartman is responsible for ensuring the optimal use and development of electronic clinical surveillance and quality improvement solutions.
“Dr. Hartman is an expert in the field of medication safety and has the knowledge and expertise necessary to support our team in the development and advancement of clinical surveillance and quality improvement solutions,” said Tim Gibbons, Vice President & General Manager, Pharmacy OneSource, Wolters Kluwer Health Clinical Solutions.
Dr. Hartman is founder and president of the American Society of Medication Safety Officers, a professional organization representing medication safety officers at healthcare organizations. He is also an assistant professor of medicine and nursing at the University of Massachusetts Medical School, an adjunct professor of pharmacy practice at the Massachusetts College of Pharmacy and Health Sciences and the University of Rhode Island, and a clinical assistant professor of pharmacy practice at Northeastern University.
Recently, Dr. Hartman was appointed to chair a Special Commission to enhance oversight of Massachusetts’ pharmacy compounding industry. The Special Commission was created in the wake of a fatal fungal meningitis outbreak that was traced back to a Massachusetts-based compounding pharmacy.
Prior to joining Pharmacy OneSource, Dr. Hartman served as a senior research pharmacist at Brigham and Women’s Hospital in Boston. Previously, he was the first Medication Safety Officer at UMass Memorial Medical Center in Worcester, Mass., where he created the first accredited post-doctoral residency program in medication safety. During his tenure, UMass had three successful Joint Commission accreditation visits with no medication management RFIs. Dr. Hartman also converted the organization to electronic error reporting, increased error reporting by 150% and created an electronic solution to detect potential adverse drug events using the IHI Global Trigger tool and IHI 5 Million Lives: Preventing Harm from High Alert Medications.
Dr. Hartman received his bachelor’s degree in pharmacy from the Massachusetts College of Pharmacy in Boston and Doctorate from the University of Kansas. He completed a fellowship in patient safety at the Virginia Commonwealth University and holds an MBA from the Isenberg School of Management at UMass-Amherst.
Dr. Hartman has served as the president of Massachusetts Society of Health-System Pharmacists (MSHP) and MSHP Foundation, the ASHP Section Advisory Group for Medication Safety, ASHP Section Advisory Group for Compliance and Quality, and University HealthSystem Consortium Pharmacy Council Committee for Medication Use and Technology. Dr. Hartman is a Fellow of the American Society of Medication Safety Officers and currently serves on the Advisory Board to Decision Health Medication Management Error Elimination.